Takahiro Tomiyama

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.

Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 08, 2025

Preclinical assessment of oral TLR7 agonist SA-5 in a nonhuman primate model.

Preclinical assessment of oral TLR7 agonist SA-5 in a nonhuman primate model.

Journal: JCI insight

Published: June 16, 2025

PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes.

PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes.

Journal: JCI insight

Published: March 24, 2025

Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma.

Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma.

Journal: Annals of surgical oncology

Published: January 08, 2025

Induced pluripotent stem cell-derived stellate cells promote proliferation of induced pluripotent stem cell-derived hepatocytes through the mitogen-activated protein kinase pathway via hepatocyte growth factor.

Induced pluripotent stem cell-derived stellate cells promote proliferation of induced pluripotent stem cell-derived hepatocytes through the mitogen-activated protein kinase pathway via hepatocyte growth factor.

Journal: Surgery today

Published: November 19, 2024

What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?

What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?

Journal: Transplantation

Published: February 27, 2024

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis.

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis.

Journal: Liver cancer

Published: January 20, 2024

Prediction of portal venous pressure in living donor liver transplantation: A retrospective study.

Prediction of portal venous pressure in living donor liver transplantation: A retrospective study.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: December 29, 2023

The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter.

The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter.

Journal: Journal of virological methods

Published: September 29, 2023

Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment.

Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 17, 2023

Feasibility of venous cuff using an open round ligament or inferior mesenteric vein around the hepatic vein for a left lobe graft in living-donor liver transplantation.

Feasibility of venous cuff using an open round ligament or inferior mesenteric vein around the hepatic vein for a left lobe graft in living-donor liver transplantation.

Journal: Surgery today

Published: August 13, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026